Moreover, mouse studies have also shown that hypermethylation of p16/Ink4a and p19/Arf in asbestos-induced inflammatory lesions precedes mesothelioma, resulting in silencing of cdkn2A (Ink4a/Arf) and loss of p16 and p19 protein20. The gene discussed is CDKN2A; the disease is mesothelioma.